ACM
OACCU

ADAR1 Capital Management’s Oaktree Acquisition Corp III Life Sciences Unit OACCU Stock Holding History

ADAR1 Capital Management’s Portfolio OACCU Stock Details OACCU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.5M Hold
516,482
– – 0.32% 70
2025
Q4 		$5.49M Hold
516,482
– – 0.4% 56
2025
Q3 		$5.48M Hold
516,482
– – 0.51% 46
2025
Q2 		$5.48M Hold
516,482
– – 0.84% 32
2025
Q1 		$5.39M Buy
516,482
+16,482
+3% +$168K 1% 29
2024
Q4 		$5.07M Buy
+500,000
New +$5.04M 1.01% 25

Other funds holding OACCU

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return

ADAR1 Capital Management's OACCU Position: Q1 2026 in Review

ADAR1 Capital Management held its Oaktree Acquisition Corp III Life Sciences Unit (OACCU) position steady in Q1 2026 at 516,482 shares worth $5.5M. The position accounts for 0.32% of the portfolio, ranked #70.

ADAR1 Capital Management first reported a position in OACCU in Q4 2024 and has held it in 6 quarters since. 6 funds tracked by Wall St. Rank hold OACCU as of Q1 2026.

  • ADAR1 Capital Management held 516,482 shares of Oaktree Acquisition Corp III Life Sciences Unit worth $5.5M as of Q1 2026.
  • ADAR1 Capital Management left its Oaktree Acquisition Corp III Life Sciences Unit share count unchanged in Q1 2026.
  • Oaktree Acquisition Corp III Life Sciences Unit made up 0.32% of ADAR1 Capital Management's portfolio in Q1 2026, its #70 holding.
  • ADAR1 Capital Management first reported a position in Oaktree Acquisition Corp III Life Sciences Unit in Q4 2024 and has held it in 6 quarters since.
  • 6 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Unit as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.